250 related articles for article (PubMed ID: 32345341)
1. Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria.
Cheng XY; Biswas S; Li J; Mao CJ; Chechneva O; Chen J; Li K; Li J; Zhang JR; Liu CF; Deng WB
Transl Neurodegener; 2020 Apr; 9(1):13. PubMed ID: 32345341
[TBL] [Abstract][Full Text] [Related]
2. Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.
De Miranda BR; Rocha EM; Bai Q; El Ayadi A; Hinkle D; Burton EA; Timothy Greenamyre J
Neurobiol Dis; 2018 Jul; 115():101-114. PubMed ID: 29649621
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes protect MN9D neuronal cells against rotenone-induced oxidative stress by a glutathione-dependent mechanism.
Cao Q; Wei LR; Lu LL; Zhao CL; Zhao HY; Yang H
Sheng Li Xue Bao; 2007 Jun; 59(3):253-9. PubMed ID: 17579777
[TBL] [Abstract][Full Text] [Related]
4. The neuroprotective effect of human uncoupling protein 2 (hUCP2) requires cAMP-dependent protein kinase in a toxin model of Parkinson's disease.
Hwang RD; Wiemerslage L; LaBreck CJ; Khan M; Kannan K; Wang X; Zhu X; Lee D; Fridell YW
Neurobiol Dis; 2014 Sep; 69():180-91. PubMed ID: 24965893
[TBL] [Abstract][Full Text] [Related]
5. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.
Kostuk EW; Cai J; Iacovitti L
Glia; 2019 Aug; 67(8):1542-1557. PubMed ID: 31025779
[TBL] [Abstract][Full Text] [Related]
6. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z
J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes Attenuate Mitochondrial Dysfunctions in Human Dopaminergic Neurons Derived from iPSC.
Du F; Yu Q; Chen A; Chen D; Yan SS
Stem Cell Reports; 2018 Feb; 10(2):366-374. PubMed ID: 29396183
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection of GLP-1/GIP receptor agonist via inhibition of mitochondrial stress by AKT/JNK pathway in a Parkinson's disease model.
Li T; Tu L; Gu R; Yang XL; Liu XJ; Zhang GP; Wang Q; Ren YP; Wang BJ; Tian JY
Life Sci; 2020 Sep; 256():117824. PubMed ID: 32445758
[TBL] [Abstract][Full Text] [Related]
9. LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson's Disease Cell Model.
Zheng W; Han X; Han B; Li G; Gan J; Wang T; Xu B; He J; Du W; Cao X; Wang Z
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446291
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 knock-down impairs astrocyte mitochondrial function.
Larsen NJ; Ambrosi G; Mullett SJ; Berman SB; Hinkle DA
Neuroscience; 2011 Nov; 196():251-64. PubMed ID: 21907265
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the rotenone-induced activation of the Nrf2 pathway in a neuronal model derived from human induced pluripotent stem cells.
Zagoura D; Canovas-Jorda D; Pistollato F; Bremer-Hoffmann S; Bal-Price A
Neurochem Int; 2017 Jun; 106():62-73. PubMed ID: 27615060
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 pathway activation upon rotenone treatment in human iPSC-derived neural stem cells undergoing differentiation towards neurons and astrocytes.
Pistollato F; Canovas-Jorda D; Zagoura D; Bal-Price A
Neurochem Int; 2017 Sep; 108():457-471. PubMed ID: 28627367
[TBL] [Abstract][Full Text] [Related]
13. shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model.
Zharikov AD; Cannon JR; Tapias V; Bai Q; Horowitz MP; Shah V; El Ayadi A; Hastings TG; Greenamyre JT; Burton EA
J Clin Invest; 2015 Jul; 125(7):2721-35. PubMed ID: 26075822
[TBL] [Abstract][Full Text] [Related]
14. Lithium protects dopaminergic cells from rotenone toxicity via autophagy enhancement.
Hou L; Xiong N; Liu L; Huang J; Han C; Zhang G; Li J; Xu X; Lin Z; Wang T
BMC Neurosci; 2015 Nov; 16():82. PubMed ID: 26608648
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic neurons are preferentially sensitive to long-term rotenone toxicity in primary cell culture.
Radad K; Gille G; Rausch WD
Toxicol In Vitro; 2008 Feb; 22(1):68-74. PubMed ID: 17923380
[TBL] [Abstract][Full Text] [Related]
17. Phenothiazine normalizes the NADH/NAD
Tapias V; McCoy JL; Greenamyre JT
Redox Biol; 2019 Jun; 24():101164. PubMed ID: 30925294
[TBL] [Abstract][Full Text] [Related]
18. SC79, a novel Akt activator, protects dopaminergic neuronal cells from MPP
Zhu JL; Wu YY; Wu D; Luo WF; Zhang ZQ; Liu CF
Mol Cell Biochem; 2019 Nov; 461(1-2):81-89. PubMed ID: 31342299
[TBL] [Abstract][Full Text] [Related]
19. Astrocytes rescue neuronal health after cisplatin treatment through mitochondrial transfer.
English K; Shepherd A; Uzor NE; Trinh R; Kavelaars A; Heijnen CJ
Acta Neuropathol Commun; 2020 Mar; 8(1):36. PubMed ID: 32197663
[TBL] [Abstract][Full Text] [Related]
20. Valeric Acid Protects Dopaminergic Neurons by Suppressing Oxidative Stress, Neuroinflammation and Modulating Autophagy Pathways.
Jayaraj RL; Beiram R; Azimullah S; Mf NM; Ojha SK; Adem A; Jalal FY
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
